LeMaitre Vascular (LMAT) DIvidends Date & History

Key Takeaways

• Modest yield: LMAT pays a quarterly dividend of $0.25 per share ($1.00 annualized), equating to a dividend yield of roughly 0.9% — well below the broader market and its industry median.
• Strong growth streak: LeMaitre Vascular has increased its dividend for 15 consecutive years, supported by a five-year dividend compound annual growth rate (CAGR) in the low-to-mid teens.
• Highly sustainable: The dividend payout ratio sits around 33–34% of earnings, with a similarly conservative cash-flow payout ratio, leaving ample room for future increases.
• Clean balance sheet: The company's minimal debt and consistent profitability reinforce the reliability of its payouts.
• Best fit: The stock is most appealing to dividend growth and long-term investors rather than those seeking high current income.

Dividend Overview

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a medical device company specializing in devices for the treatment of peripheral vascular disease. The company pays a cash dividend on a quarterly basis, with its most recent payment set at $0.25 per share, bringing the annualized dividend to $1.00 per share. Based on the company's recent share price, this translates to a dividend yield of approximately 0.9%, which is relatively modest.

Despite the low yield, LeMaitre is best classified as a dividend growth stock rather than a high-yield or income stock. Its payout has climbed steadily over the past decade and a half, reflecting management's commitment to returning a portion of earnings to shareholders while reinvesting the remainder to fund organic growth and acquisitions. The low yield primarily reflects the stock's strong price appreciation over time, not a shrinking dividend.

Dividend History and Growth

LeMaitre Vascular has a well-established record of consistent, predictable dividend payments. The company has raised its dividend for 15 consecutive years, a streak that places it among a relatively small group of dividend growers in the healthcare and medical device space. Dividends are paid quarterly, providing shareholders with a regular, reliable income stream.

The pace of increases has been notable. The quarterly dividend was raised from $0.16 per share in 2024 to $0.20 per share in 2025 — a 25% increase — and then again to $0.25 per share in 2026. Over the trailing five years, the dividend has compounded at an annualized rate in the low-to-mid teens, a growth trajectory that ranks among the strongest in its sector. This pattern reflects a disciplined, long-term strategy of rewarding shareholders while preserving capital for reinvestment.

Dividend Sustainability and Payout Ratio

LeMaitre's dividend appears highly sustainable. The company's payout ratio — the proportion of earnings distributed as dividends — stands at roughly 33–34%, a conservative level that leaves a substantial cushion for operational needs and future increases. On a cash-flow basis, the payout is similarly low, indicating the dividend is comfortably covered by free cash flow rather than debt or borrowed capital.

The company's financial position further supports dividend reliability. LeMaitre maintains a conservative balance sheet with minimal debt, and its consistent profitability and cash generation provide a stable foundation for continued distributions. Because management keeps the payout ratio low, the dividend is unlikely to be threatened by modest fluctuations in quarterly earnings and leaves meaningful room for the growth streak to continue.

Dividend Compared to Industry Peers

Within the medical device and healthcare equipment sector, LeMaitre Vascular's dividend yield of roughly 0.9% is below the industry median, which generally falls in the 1.5% to 2.0% range or higher. Many larger, more mature healthcare companies offer higher current yields, making LeMaitre less competitive for pure income investors.

However, the comparison shifts meaningfully when dividend growth is considered. LeMaitre's double-digit dividend growth rate and 15-year increase streak stand out relative to many peers, whose yields are higher but whose distributions grow more slowly or remain static. In other words, LeMaitre trades a lower current yield for a faster-growing payout — a profile that favors investors with a longer time horizon over those seeking immediate income.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and other market opportunities more efficiently than manual screening. Investors researching names like LMAT can use the AI Screener to compare dividend profiles, growth streaks, and financial metrics across an entire industry.

Is This Stock Attractive for Dividend Investors?

LeMaitre Vascular is best suited to dividend growth and long-term investors rather than those seeking high current income. Its sub-1% yield is unlikely to satisfy investors who depend on substantial cash distributions today. Instead, the company's appeal lies in its 15-year track record of rising payouts and its conservative, well-covered dividend, which suggests the growth streak has room to continue.

For investors with a multi-year horizon, the combination of a low payout ratio, minimal debt, and double-digit historical dividend growth offers the potential for meaningful income growth over time. Total-return-oriented investors may also appreciate the discipline of a growing dividend alongside the company's reinvestment in its core vascular business.

Conversely, conservative, income-focused investors who prioritize yield above all else may find more attractive options elsewhere in the healthcare sector. As always, the suitability of any dividend stock depends on an individual's goals, time horizon, and risk tolerance, and past dividend performance does not guarantee future results.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations